Acasti Pharma, Inc. (ACST)

Acasti Pharma (ACST) Financial Statements


Acasti Pharma Financial Overview

Acasti Pharma's market cap is currently ―. The company's EPS TTM is $-0.388; its P/E ratio is -1.40; Acasti Pharma is scheduled to report earnings on June 28, 2023, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit---$ 0.00$ 0.00
EBIT$ -4.23M$ -5.11M$ -4.73M$ -4.40M$ -4.22M
EBITDA-$ -5.12M$ -4.56M$ -4.40M$ -4.22M
Net Income Common Stockholders$ -3.89M$ -4.93M$ -4.52M$ -3.90M$ -3.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.26M$ 34.94M$ 38.39M$ 43.66M$ 46.33M
Total Assets$ 116.80M$ 120.91M$ 124.93M$ 128.62M$ 114.23M
Total Debt$ 503.00K$ 520.00K$ 819.00K$ 295.00K$ 22.00K
Net Debt$ -30.75M$ -34.42M$ -37.57M$ -43.37M$ -46.30M
Total Liabilities$ 20.08M$ 20.75M$ 20.53M$ 20.35M$ 3.17M
Stockholders Equity$ 96.72M$ 100.16M$ 104.40M$ 108.27M$ 111.06M
Cash Flow-
Free Cash Flow$ -12.60M$ -3.44M$ -5.43M$ -3.15M$ -4.58M
Operating Cash Flow$ -12.59M$ -3.44M$ -5.43M$ -3.15M$ -4.58M
Investing Cash Flow$ 8.16M$ -96.00K$ 13.26M$ 11.00K$ 557.00K
Financing Cash Flow$ 304.00K$ 109.00K$ 195.00K$ 0.00$ 0.00
Currency in USD

Acasti Pharma Earnings and Revenue History

Acasti Pharma Debt to Assets

Acasti Pharma Cash Flow

Acasti Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis